| scholarly article | Q13442814 |
| P2093 | author name string | Iva Navratilova | |
| Andrew L Hopkins | |||
| P2860 | cites work | Discovery of a novel warhead against beta-secretase through fragment-based lead generation | Q27648962 |
| Tyramine fragment binding to BACE-1 | Q27649725 | ||
| Recent developments in fragment-based drug discovery | Q27650535 | ||
| Ligand efficiency: a useful metric for lead selection | Q29617403 | ||
| Lessons for fragment library design: analysis of output from multiple screening campaigns | Q30864260 | ||
| Fragment library screening and lead characterization using SPR biosensors | Q30904689 | ||
| Druggability indices for protein targets derived from NMR-based screening data | Q30986175 | ||
| SPR-based fragment screening: advantages and applications | Q33304863 | ||
| Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels | Q33319538 | ||
| Fragment-based screening using surface plasmon resonance technology | Q33436591 | ||
| Recent progress in fragment-based lead discovery | Q33455221 | ||
| Predicting protein druggability | Q36352932 | ||
| Do enthalpy and entropy distinguish first in class from best in class? | Q36967464 | ||
| From fragment to clinical candidate--a historical perspective. | Q37475509 | ||
| Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors | Q42063999 | ||
| Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. | Q53010783 | ||
| Identification of MMP-12 Inhibitors by Using Biosensor-Based Screening of a Fragment Library | Q56945048 | ||
| Thermodynamic benchmark study using Biacore technology | Q57266892 | ||
| Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors | Q80463480 | ||
| P4510 | describes a project that uses | surface plasmon resonance | Q898756 |
| P433 | issue | 1 | |
| P921 | main subject | surface plasmon resonance | Q898756 |
| P304 | page(s) | 44-48 | |
| P577 | publication date | 2010-02-04 | |
| P1433 | published in | ACS Medicinal Chemistry Letters | Q2819061 |
| P1476 | title | Fragment screening by surface plasmon resonance | |
| P478 | volume | 1 |
| Q37289583 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| Q35837615 | A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening |
| Q35025905 | A three-stage biophysical screening cascade for fragment-based drug discovery. |
| Q47096060 | An update on anticancer drug development and delivery targeting carbonic anhydrase IX. |
| Q98771871 | Application of Fragment-Based Drug Discovery to Versatile Targets |
| Q34987728 | Biophysical characterization of G-protein coupled receptor-peptide ligand binding |
| Q54551290 | Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action. |
| Q33928781 | Biosensor-based small molecule fragment screening with biolayer interferometry. |
| Q35532349 | Composing compound libraries for hit discovery--rationality-driven preselection or random choice by structural diversity? |
| Q28543133 | Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design |
| Q90193281 | Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR |
| Q34897783 | Development of fragment-based n-FABS NMR screening applied to the membrane enzyme FAAH. |
| Q47380200 | Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods. |
| Q31148599 | Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor. |
| Q34049517 | Emerging role of surface plasmon resonance in fragment-based drug discovery. |
| Q35009555 | Evolutions in fragment-based drug design: the deconstruction-reconstruction approach |
| Q28833921 | Fragment Screening of Human Aquaporin 1 |
| Q26826945 | Fragment screening and HIV therapeutics |
| Q33836468 | Fragment screening of infectious disease targets in a structural genomics environment |
| Q27676858 | Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors |
| Q38587368 | Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities |
| Q35181268 | Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery |
| Q38946242 | Identification of structural features of 2-alkylidene-1,3-dicarbonyl derivatives that induce inhibition and/or activation of histone acetyltransferases KAT3B/p300 and KAT2B/PCAF. |
| Q92443122 | Identifying Ortholog Selective Fragment Molecules for Bacterial Glutaredoxins by NMR and Affinity Enhancement by Modification with an Acrylamide Warhead |
| Q90056903 | In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery |
| Q30452210 | Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target |
| Q40054877 | Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors. |
| Q27697268 | Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologies |
| Q35593223 | Medicinal chemistry for 2020 |
| Q90198579 | NMR-based fragment screening and lead discovery accelerated by principal component analysis |
| Q35741775 | One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists |
| Q26738768 | Process of Fragment-Based Lead Discovery-A Perspective from NMR |
| Q37940197 | Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions |
| Q34549950 | Protein-Templated Fragment Ligations-From Molecular Recognition to Drug Discovery. |
| Q92096445 | Proteintemplat-gesteuerte Fragmentligationen - von der molekularen Erkennung zur Wirkstofffindung |
| Q64118556 | Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance-Based Fragment Screening |
| Q33959477 | Screening a fragment cocktail library using ultrafiltration |
| Q57282783 | The role of small-angle scattering in structure-based screening applications |
| Q89476923 | Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
Search more.